These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6888085)

  • 61. Coating charcoal with polyacrylate-polymethacrylate copolymer for haemoperfusion. II. Drug removal and polymer compatibility studies.
    el-Kheshen S; Zia H; Needham TE; Badawi A; Luzzi LA
    J Microencapsul; 1994; 11(1):3-10. PubMed ID: 8138872
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Removal of alpha-amanitin from blood by hemoperfusion over uncoated charcoal. Experimental results.
    Masini E; Blandina P; Mannaioni PF
    Contrib Nephrol; 1982; 29():76-81. PubMed ID: 7075219
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The porphyrias, appropriate test selection.
    Hindmarsh JT
    Clin Chim Acta; 2003 Jul; 333(2):203-7. PubMed ID: 12849906
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hemoadsorption of high-mobility group box chromosomal protein 1 using a column for large animals.
    Nishiyama R; Shinoda M; Tanabe M; Oshima G; Takano K; Miyasho T; Fuchimoto Y; Yamada S; Inoue T; Shimada K; Suda K; Tanaka M; Hayashida T; Yagi H; Kitago M; Obara H; Itano O; Takeuchi H; Kawachi S; Maruyama I; Kitagawa Y
    Eur Surg Res; 2013; 51(3-4):181-90. PubMed ID: 24434684
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The development of a new hemoperfusion column: the filmadsorber.
    van Berlo A; Verkooyen A; Tangerman A
    Int J Artif Organs; 1982 May; 5(3):181-4. PubMed ID: 7107054
    [TBL] [Abstract][Full Text] [Related]  

  • 66. ACAC (albumin-collodion coated activated charcoal) hemoperfusion: in-vitro removal and clearance of theophylline.
    Espinosa-Meléndez E; Chang TM
    J Dial; 1980; 4(1):21-9. PubMed ID: 7410675
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influence of hemoperfusion on the concentrations of calcitonin, testosterone and cortisol in blood plasma.
    Kokot F; Nieszporek T
    Artif Organs; 1979 Nov; 3(4):332-5. PubMed ID: 533422
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hemoperfusion for methotrexate removal.
    Gibson TP; Reich SD; Krumlovsky FA; Ivanovich P; Gonczy C
    Clin Pharmacol Ther; 1978 Mar; 23(3):351-5. PubMed ID: 627142
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Extracorporeal elimination of carbamazepine by haemoperfusion.
    Kuhlmann U; Becker R; Ebel H; Gressner A; Lange H
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(5):1171-6. PubMed ID: 1457691
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Augmented hemoperfusion for hyperbilirubinemia.
    Brian BF; Dorson WJ; Pizziconi VB; Ramseyer PJ; Brooker JE
    ASAIO Trans; 1988; 34(3):585-9. PubMed ID: 3196567
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of Mechanical Vibration on Kinetics of Solute Adsorption.
    Ramírez-Guerrero G; Reis T; Lorenzin A; Marcello M; de Cal M; Zanella M; Ronco C
    Blood Purif; 2024; 53(6):500-504. PubMed ID: 38281478
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rates of heparin adsorption in hemoperfusion devices.
    Cooney DO
    Clin Toxicol; 1979 Oct; 15(3):287-91. PubMed ID: 509892
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Elimination of meproscillarin by hemoperfusion (author's transl)].
    Rupp M; Brass H; Belz GG
    Arzneimittelforschung; 1978; 28(3a):567-9. PubMed ID: 580593
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hemoperfusion in the management of digoxin toxicity.
    Smiley JW; March NM; Del Guercio ET
    JAMA; 1978 Dec; 240(25):2736-7. PubMed ID: 713006
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Hemoperfusion through adsorbents].
    García Pérez JJ; Redondo Rodríguez M; Torres Ramírez A; Méndez Pérez ML; Maceira Cruz B; Bueno Gómez J
    Rev Clin Esp; 1979 Feb; 152(4):331-5. PubMed ID: 451313
    [No Abstract]   [Full Text] [Related]  

  • 76. Comparative studies of hemoperfusion devices. I. In vitro clearance characteristics.
    Cooney DO; Infantolino W; Kane R
    Biomater Med Devices Artif Organs; 1978; 6(3):199-213. PubMed ID: 728514
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An economical hemoperfusion system to determine in vitro clearances of various poisons with different adsorbents.
    Okonek S; Reininghaus I; Setyadharma H; Gaudron P
    Arch Toxicol; 1980 Dec; 46(3-4):215-20. PubMed ID: 7236003
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro adsorption of oxalic acid and glyoxylic acid onto activated charcoal, resins and hydrous zirconium oxide.
    Scholtens R; Scholten J; de Koning HW; Tijssen J; ten Hoopen HW; Olthuis FM; Feijen J
    Int J Artif Organs; 1982 Jan; 5(1):33-6. PubMed ID: 7068263
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vancomycin Adsorption During in vitro Model of Hemoperfusion with HA380 Cartridge.
    Godi I; Lorenzin A; De Rosa S; Golino G; Knust M; Gaspar A; Sandini A; Fiorin F; de Cal M; Navalesi P; Ronco C
    Nephron; 2021; 145(2):157-163. PubMed ID: 33567447
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regional arterial infusion of an anticancer drug combined with direct hemoperfusion.
    Harada T; Ohmura H; Nishizawa O; Tsuchida S
    Tohoku J Exp Med; 1981 Apr; 133(4):423-9. PubMed ID: 7256733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.